Technical Analysis for NTUS - Natus Medical Incorporated

Grade Last Price % Change Price Change
grade C 32.35 -0.92% -0.30
NTUS closed down 0.92 percent on Monday, November 11, 2019, on 57 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical NTUS trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
20 DMA Resistance Bearish -0.92%
Narrow Range Bar Range Contraction -0.92%
NR7 Range Contraction -0.92%
Inside Day Range Contraction -0.92%
Fell Below 20 DMA Bearish -0.31%
MACD Bearish Signal Line Cross Bearish -0.31%
Slingshot Bullish Bullish Swing Setup -0.31%
Wide Range Bar Range Expansion -0.31%
Bearish Engulfing Bearish -3.23%

Older signals for NTUS ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing screening products; diagnostic hearing assessment products to screen for/or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems; balance and mobility systems to diagnose and assist in treating balance disorders; and thermoregulation products to control the incubators and warmers. Additionally, it offers jaundice management products; brain injury products; NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation and sound rooms to hearing and balance care professionals. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Pleasanton, California.
Medicine Health Medical Specialties Diseases Disorders Nursing Epilepsy Infancy Sleep Disorders Intensive Care Medicine Software Systems Hearing Loss Audiology Streaming Video Neonatal Intensive Care Unit Neonatology
Is NTUS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 35.73
52 Week Low 22.25
Average Volume 163,406
200-Day Moving Average 28.2747
50-Day Moving Average 31.4496
20-Day Moving Average 32.862
10-Day Moving Average 33.299
Average True Range 1.0149
ADX 10.35
+DI 17.7533
-DI 22.9524
Chandelier Exit (Long, 3 ATRs ) 31.8453
Chandelier Exit (Short, 3 ATRs ) 32.7147
Upper Bollinger Band 34.5249
Lower Bollinger Band 31.1991
Percent B (%b) 0.35
BandWidth 10.120504
MACD Line 0.4567
MACD Signal Line 0.6269
MACD Histogram -0.1701
Fundamentals Value
Market Cap 1.05 Billion
Num Shares 32.5 Million
EPS 0.58
Price-to-Earnings (P/E) Ratio 55.78
Price-to-Sales 2.93
Price-to-Book 3.06
PEG Ratio 1.06
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 33.19
Resistance 3 (R3) 33.22 32.97 33.05
Resistance 2 (R2) 32.97 32.76 32.96 33.00
Resistance 1 (R1) 32.66 32.62 32.54 32.63 32.96
Pivot Point 32.41 32.41 32.35 32.40 32.41
Support 1 (S1) 32.10 32.20 31.98 32.07 31.74
Support 2 (S2) 31.85 32.06 31.84 31.70
Support 3 (S3) 31.54 31.85 31.65
Support 4 (S4) 31.51